Table 2.
Collection time | Samples collected | Number sampled | Testing |
---|---|---|---|
Birth | Blood | Subseta, n = 169 |
n = 169 Maternal anti-BCV IgG |
Initial vaccination | Blood, NSb | All study calvesc |
n = 60 each herd, 180 total Blood: anti-BCV IgG NS: subclinical virus shedding |
Preconditioning | Blood, NS | All study calves |
n = 60 each herd, 180 total Blood: anti-BCV IgG NS: subclinical virus shedding |
Weaning | Blood, NS | All study calves |
n = 60 each herd, 180 total Blood: anti-BCV IgG NS: subclinical virus shedding |
At time of treatment for BRD | Blood, NS |
n = 234 (including mass treatments) |
Blood: anti-BCV IgG NS: detection of viral and bacterial pathogens |
aBlood was collected between 18 and 48 h after birth from a small subset of calves for which both birth and the first nursing episode were observed to ensure chance for colostrum uptake
bNS, nasal swabs
c817 calves were sampled for this study, see Table 1